Amerinet, a national healthcare group purchasing organization, has announced its private-label and sourcing company Amerinet Choice has signed an agreement with Sandoz, a division of the Novartis group, for Gemcitabine HCL and Levofloxacin/Dextrose pharmaceutical products.
The contract offers savings to Amerinet members on common 1 gram or 200 milligram powdered vials of Gemcitabine HCL and three different pre-mixed bags of Levofloxacin/Dextrose, according to an Amerinet news release.
The agreement is effective through Sept. 30, 2014.
Read the news release about the Sandoz agreement with Amerinet.
View all new Amerinet agreements.
More Articles Featuring Amerinet:
Amerinet Publishes Executive Briefing on Healthcare Reform and Accountable Care
Amerinet to Host Webinar Series on EMR and Meaningful Use Compliance
Patient Safety Tool: Amerinet Safe Handling of Hazardous Drugs Toolkit